SBC Medical Group Holdings Incorporated (SBC)

NASDAQ: SBC · Real-Time Price · USD

3.060

+0.020 (0.66%)

At close: Jul 31, 2026, 4:00 PM EDT

3.050

-0.010 (-0.33%)

After-hours: Jul 31, 2026, 7:01 PM EDT

SBC Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	40.88	51.05	46.69	38.56	5.55
Depreciation & Amortization	2.73	2.68	3.8	12.25	5.93
Stock-Based Compensation	-	-	13.02	-	-
Other Adjustments	-5.78	-2.53	3.96	7.51	-0.94
Change in Receivables	-5.61	1.39	0.62	-23	-2.86
Changes in Inventories	0.4	-0.17	1.12	-1.83	-0.67
Changes in Accounts Payable	1.36	2.67	-8.91	12.2	0.17
Changes in Accrued Expenses	3.45	2.97	-12.1	4.45	2.67
Changes in Income Taxes Payable	5.73	-11.66	11.23	13.36	-8.54
Changes in Unearned Revenue	-5.1	-6.09	-10.62	-3.8	2.48
Changes in Other Operating Activities	-10.3	-15.64	-28.23	-9.04	-3.84
Operating Cash Flow	31.97	24.67	20.58	50.67	-0.05
Operating Cash Flow Growth	69.80%	19.85%	-59.38%	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Capital Expenditures	-2.16	-2.37	-3.41	-9.52	-24.95
Sale of Property, Plant & Equipment	7.16	7.48	-	8.05	2.24
Purchases of Intangible Assets	-	-	-	-1.68	-
Purchases of Investments	-0.02	-21.48	-2.03	-3.13	-2.65
Proceeds from Sale of Investments	-	18.19	-	8.08	-
Cash Acquisitions	-	-22.94	-4.24	0.72	-6.49
Proceeds from Business Divestments	-	-	-0.83	-	-
Other Investing Activities	1.92	0.14	0.41	-0.72	-0.81
Investing Cash Flow	-20.52	-20.97	-10.1	1.79	-32.65

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Long-Term Debt Issued	-	34.77	12.09	12.31	0.12
Long-Term Debt Repaid	-3.23	-1.5	-0.86	-16.44	-6.57
Net Long-Term Debt Issued (Repaid)	-3.23	33.27	11.23	-4.13	-6.45
Issuance of Common Stock	-	-	11.74	0	-
Repurchase of Common Stock	-	-5	-	-	-
Net Common Stock Issued (Repurchased)	-	-5	11.74	0	-
Other Financing Activities	-0.15	10.02	-	10.26	-1.53
Financing Cash Flow	36.73	38.29	22.97	6.14	-7.98

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Foreign Exchange Rate Adjustments	-12.93	-3.26	-11.42	-7.31	-12.09
Net Cash Flow	35.25	38.73	22.02	51.28	-52.77

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Free Cash Flow	29.81	22.3	17.17	41.15	-24.99
Free Cash Flow Growth	78.35%	29.84%	-58.26%	-	-
FCF Margin	17.60%	12.84%	8.36%	21.26%	-14.35%
Free Cash Flow Per Share	0.29	0.22	0.18	0.44	-3.14
Levered Free Cash Flow	33.65	56.64	10.73	53.31	-26.88
Unlevered Free Cash Flow	31.99	14.36	-2.42	55.1	-22.03

SEC Filings: 10-K · 10-Q